Literature DB >> 29216983

Atrial Infarction and Ischemic Mitral Regurgitation Contribute to Post-MI Remodeling of the Left Atrium.

Jaume Aguero1, Carlos Galan-Arriola2, Rodrigo Fernandez-Jimenez3, Javier Sanchez-Gonzalez4, Nina Ajmone5, Victoria Delgado5, Jorge Solis6, Gonzalo J Lopez7, Antonio de Molina-Iracheta7, Roger J Hajjar8, Jeroen J Bax5, Valentin Fuster9, Borja Ibáñez10.   

Abstract

BACKGROUND: Left atrial (LA) remodeling after an acute myocardial infarction (MI) is poorly characterized regarding its determinants or its effect on ischemic mitral regurgitation (MR) development.
OBJECTIVES: The purpose of this study was: 1) to compare LA structural remodeling in experimental MI swine models recapitulating the effects of left ventricular (LV) dysfunction, ischemic MR, and left atrial infarction (LAI); and 2) to analyze how LA remodeling influences ischemic MR development.
METHODS: Three models of MI were generated: 1) proximal left circumflex (LCx) coronary artery occlusion involving the LA branch (LAI group); 2) proximal LCx occlusion not involving the LA branch (LCx group); and 3) left anterior descending (LAD) occlusion (LAD group). Serial cardiac magnetic resonance scans were performed to define LA and LV remodeling and ischemic MR, and were correlated with histology.
RESULTS: Occlusion of the LA branch (LAI group) induced a greater degree of LA dilation at 1 and 8 weeks post-MI than the LCx and LAD groups, along with early and severe impairment of LA function. In the LCx and LAD groups, LA dysfunction was less pronounced and not consistent. Development of ischemic MR was more pronounced in the LAI group than in the LCx group. Histology confirmed atrial infarction with extensive fibrosis in the LAI group and interstitial fibrosis in the LCx group. In the LAD group, LA remodeling was not observed by cardiac magnetic resonance or histology.
CONCLUSIONS: We provide the first experimental evidence of the deleterious effect of acute LAI on atrial structural remodeling, characterized by early LA dilation, dysfunction, and fibrosis, and early occurrence of ischemic MR.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrosis; atrial infarction; experimental model; mitral regurgitation; myocardial infarction

Mesh:

Year:  2017        PMID: 29216983     DOI: 10.1016/j.jacc.2017.10.013

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

Review 1.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

2.  Culprit vessel-related myocardial mechanics and prognostic implications following acute myocardial infarction.

Authors:  Sören J Backhaus; Johannes T Kowallick; Thomas Stiermaier; Torben Lange; Alexander Koschalka; Jenny-Lou Navarra; Joachim Lotz; Shelby Kutty; Boris Bigalke; Matthias Gutberlet; Hans-Josef Feistritzer; Gerd Hasenfuß; Holger Thiele; Andreas Schuster; Ingo Eitel
Journal:  Clin Res Cardiol       Date:  2019-07-05       Impact factor: 5.460

Review 3.  Contemporary narrative review on left atrial strain mechanics in echocardiography: cardiomyopathy, valvular heart disease and beyond.

Authors:  Vardhmaan Jain; Raktim Ghosh; Manasvi Gupta; Yoshihito Saijo; Agam Bansal; Medhat Farwati; Rachel Marcus; Allan Klein; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

4.  Impact of ischemia on left atrial remodeling and dysfunction in swine models of mitral regurgitation.

Authors:  Tomoki Sakata; Renata Mazurek; Spyros A Mavropoulos; Francisco J Romeo; Anjali J Ravichandran; Shin Watanabe; Taro Kariya; Kiyotake Ishikawa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 4.733

5.  Isoproterenol Increases Left Atrial Fibrosis and Susceptibility to Atrial Fibrillation by Inducing Atrial Ischemic Infarction in Rats.

Authors:  Shiyu Ma; Jin Ma; Qingqiang Tu; Chaoyang Zheng; Qiuxiong Chen; Weihui Lv
Journal:  Front Pharmacol       Date:  2020-04-15       Impact factor: 5.810

6.  Changes in Local Atrial Electrograms and Surface ECG Induced by Acute Atrial Myocardial Infarction.

Authors:  Gerard Amorós-Figueras; Elena Roselló-Diez; Damian Sanchez-Quintana; Sergi Casabella-Ramon; Esther Jorge; Jorge Nevado-Medina; Dabit Arzamendi; Xavier Millán; Concepción Alonso-Martin; Jose M Guerra; Juan Cinca
Journal:  Front Physiol       Date:  2020-04-17       Impact factor: 4.566

7.  The differences of atrial thrombus locations and variable response to anticoagulation in nonvalvular atrial fibrillation with ventricular cardiomyopathy.

Authors:  Hao Zhang; Miao Yu; Yu Xia; Xiaofeng Li; Jun Liu; Pihua Fang
Journal:  J Arrhythm       Date:  2020-08-29

8.  Atrial tachycardia related to atrial infarction treated with catheter ablation: a case report.

Authors:  Momo Fujiwara; Soichiro Yamashita; Makoto Takemoto; Takatoshi Hayashi
Journal:  Eur Heart J Case Rep       Date:  2022-08-16

9.  Asymptomatic left circumflex artery stenosis is associated with higher arrhythmia recurrence after persistent atrial fibrillation ablation.

Authors:  Rodrigue Garcia; Mathilde Clouard; Fabian Plank; Bruno Degand; Séverine Philibert; Gabriel Laurent; Pierre Poupin; Saliman Sakhy; Matthieu Gras; Markus Stühlinger; Nándor Szegedi; Szilvia Herczeg; Judit Simon; Harry J G M Crijns; Eloi Marijon; Luc Christiaens; Charles Guenancia
Journal:  Front Cardiovasc Med       Date:  2022-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.